Orchard Therapeutics
ORTX
#6330
Rank
$0.38 B
Marketcap
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)

P/S ratio for Orchard Therapeutics (ORTX)

P/S ratio as of March 2024 (TTM): 17.4

According to Orchard Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 17.405. At the end of 2023 the company had a P/S ratio of 8.04.

P/S ratio history for Orchard Therapeutics from 2019 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20238.04287.67%
20222.07-97.9%
202198.9-39.55%
2020164-69.15%
2019530

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
42.7 145.52%๐Ÿ‡บ๐Ÿ‡ธ USA
17.4 0.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.9647-94.46%๐Ÿ‡บ๐Ÿ‡ธ USA
3.29-81.12% Jersey